Delivery Order SPE2DB22D1017-SPE2DB24FF3JE
- Not listed
- This federal contract award is for the delivery of Nurtec ODT 75 mg tablets to the Defense Logistics Agency (DLA), a defense agency within the Department of Defense. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $7,504.38 and an ultimate completion date of January 13, 2022. It is a firm-fixed-price delivery order contract, with no set-aside designation. Amerisourcebergen Drug Corp...
- This federal contract award is for the delivery of Nurtec ODT 75 mg tablets to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc., which is a major pharmaceutical distributor. The contract has a ceiling value of $4,654.03 and an ultimate completion date of February 29, 2024. It is a delivery order contract with a firm fixed price pricing type. The contract was awarded on February 28,...
- This federal contract award is for the delivery of Nurtec ODT 75 mg tablets to the Defense Logistics Agency (DLA), a defense agency of the U.S. government. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $8,726.35 and a completion date of April 23, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the DLA Troop...
- This federal contract award is for the delivery of Nurtec ODT 75 mg tablets to the Defense Logistics Agency (DLA), a component of the Department of Defense (DoD). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., for a ceiling value of $6,661.51. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is January 11, 2024. The contract is not designated with a set-aside requirement, indicating...
- This federal contract award is for the delivery of Nurtec ODT 75 mg tablets to the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense (DoD). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for a ceiling value of $5,434.52. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of April 22, 2024. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp...
- This federal contract award is for the delivery of Nurtec ODT 75 mg tablets, awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $31,448.82 firm-fixed-price delivery order falls under an Indefinite Delivery Contract (IDC) between the DLA Troop Support Medical and Cencora, Inc. (doing business as AmerisourceBergen), valued at up to $999,999,999 through November 2026. This IDC serves as the primary vehicle for AmerisourceBergen to...
- This federal contract award is for the delivery of Nurtec ODT 75 mg tablets to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical distribution companies in the world. The contract is a Delivery Order with a Firm Fixed Price of $59,603.96 and an Ultimate Completion Date of April 16, 2024. It is not designated as a...
- This federal contract award is for the delivery of Nurtec ODT 75 mg tablets to the Defense Logistics Agency (DLA), a defense agency. The $21,044.64 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a pharmaceutical distributor and healthcare solutions provider, on May 9, 2025, with a completion date of May 12, 2025. The contract is not set aside. Amerisourcebergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This federal contract award is for the delivery of Nurtec ODT 75 mg tablets to the Defense Logistics Agency (DLA). The $24,489.62 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on August 11, 2023. The order has an ultimate completion date of August 14, 2023 and is not designated as a set-aside contract. AmerisourceBergen, a subsidiary of the parent company Cencora, Inc., holds a significant $999,999,999 Indefinite Delivery Contract...
- This federal contract award is for the delivery of Nurtec ODT 75 mg tablets (8 count) to the Defense Logistics Agency (DLA). The contract was awarded to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract has a firm fixed price of $3,574.06 and a ceiling value of $3,574.06, with a completion date of May 13, 2022. The contract was awarded on May 12, 2022, and there was no set-aside designation, indicating...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB24FF3JEDelivery Order
This federal contract award is for the delivery of Nurtec ODT 75 mg tablets to the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense (DoD). The contract has a ceiling value of $24,685.80 and an ultimate completion date of February 28, 2024. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a Firm Fixed Price Delivery Order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for delivering a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000, for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $24.7k | 2/27/24 |